New guidelines for the management of heart failure and AF

heart made out of pills
Researchers have welcomed recommendations for use of SGLT2 inhibitors in patients with type 2 diabetes, CVD risk, and insufficient glycaemic control despite metformin The National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand have published two sets of new guidelines: Guidelines for the Prevention, Detection, and Management of Heart Failure in

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Dust storm asthma warning
Next Minister wrong on privacy, says News Corp